CompuGroup Medical SE & Co. KGaA (COP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CompuGroup Medical SE & Co. KGaA (COP) has a cash flow conversion efficiency ratio of 0.144x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€93.91 Million ≈ $109.79 Million USD) by net assets (€652.09 Million ≈ $762.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CompuGroup Medical SE & Co. KGaA balance sheet quality to measure how much of total assets are equity-financed.
CompuGroup Medical SE & Co. KGaA - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how CompuGroup Medical SE & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CompuGroup Medical SE & Co. KGaA cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CompuGroup Medical SE & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CompuGroup Medical SE & Co. KGaA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
C*Core Technology Co Ltd
SHG:688262
|
0.051x |
|
Rategain Travel Technologies Limited
NSE:RATEGAIN
|
0.025x |
|
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
|
N/A |
|
Hagerty Inc
NYSE:HGTY
|
0.021x |
|
Barloworld Ltd
JSE:BAW
|
0.282x |
|
ARB Corporation Ltd
AU:ARB
|
0.087x |
|
Compass Minerals International Inc
NYSE:CMP
|
0.720x |
|
Nan Pao Resins Chemical Co Ltd
TW:4766
|
0.049x |
Annual Cash Flow Conversion Efficiency for CompuGroup Medical SE & Co. KGaA (2004–2024)
The table below shows the annual cash flow conversion efficiency of CompuGroup Medical SE & Co. KGaA from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see COP stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €648.31 Million ≈ $757.94 Million |
€128.88 Million ≈ $150.68 Million |
0.199x | -25.89% |
| 2023-12-31 | €669.27 Million ≈ $782.45 Million |
€179.53 Million ≈ $209.89 Million |
0.268x | +24.63% |
| 2022-12-31 | €673.82 Million ≈ $787.77 Million |
€145.03 Million ≈ $169.55 Million |
0.215x | -20.26% |
| 2021-12-31 | €612.28 Million ≈ $715.82 Million |
€165.27 Million ≈ $193.22 Million |
0.270x | +15.03% |
| 2020-12-31 | €638.94 Million ≈ $746.98 Million |
€149.93 Million ≈ $175.29 Million |
0.235x | -44.80% |
| 2019-12-31 | €259.92 Million ≈ $303.87 Million |
€110.50 Million ≈ $129.18 Million |
0.425x | -14.88% |
| 2018-12-31 | €273.00 Million ≈ $319.16 Million |
€136.35 Million ≈ $159.41 Million |
0.499x | +37.37% |
| 2017-12-31 | €236.06 Million ≈ $275.98 Million |
€85.82 Million ≈ $100.34 Million |
0.364x | +17.57% |
| 2016-12-31 | €218.65 Million ≈ $255.63 Million |
€67.61 Million ≈ $79.05 Million |
0.309x | -18.69% |
| 2015-12-31 | €192.61 Million ≈ $225.18 Million |
€73.25 Million ≈ $85.63 Million |
0.380x | +109.11% |
| 2014-12-31 | €175.63 Million ≈ $205.33 Million |
€31.94 Million ≈ $37.34 Million |
0.182x | -33.05% |
| 2013-12-31 | €192.64 Million ≈ $225.21 Million |
€52.33 Million ≈ $61.18 Million |
0.272x | -27.15% |
| 2012-12-31 | €179.41 Million ≈ $209.75 Million |
€66.91 Million ≈ $78.22 Million |
0.373x | +34.21% |
| 2011-12-31 | €168.20 Million ≈ $196.65 Million |
€46.74 Million ≈ $54.64 Million |
0.278x | +25.74% |
| 2010-12-31 | €182.73 Million ≈ $213.63 Million |
€40.38 Million ≈ $47.21 Million |
0.221x | -6.68% |
| 2009-12-31 | €185.83 Million ≈ $217.25 Million |
€44.00 Million ≈ $51.45 Million |
0.237x | +67.08% |
| 2008-12-31 | €182.82 Million ≈ $213.74 Million |
€25.91 Million ≈ $30.29 Million |
0.142x | +11.41% |
| 2007-12-31 | €198.02 Million ≈ $231.50 Million |
€25.19 Million ≈ $29.45 Million |
0.127x | -58.08% |
| 2006-12-31 | €54.37 Million ≈ $63.57 Million |
€16.50 Million ≈ $19.29 Million |
0.303x | -43.26% |
| 2005-12-31 | €44.98 Million ≈ $52.59 Million |
€24.06 Million ≈ $28.13 Million |
0.535x | -31.38% |
| 2004-12-31 | €28.87 Million ≈ $33.76 Million |
€22.51 Million ≈ $26.31 Million |
0.779x | -- |
About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical car… Read more